Click for best price
Influenza Flu Antiviral Drugs Market Size, Share 2022
Antiviral drugs are a class of drugs for the specific treatment of viral infections.
This report contains market size and forecasts of Influenza (Flu) Antiviral Drugs in Global, including the following market information:
Global Influenza (Flu) Antiviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Influenza (Flu) Antiviral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Penetration and Dehulling Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza (Flu) Antiviral Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Influenza (Flu) Antiviral Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza (Flu) Antiviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Influenza (Flu) Antiviral Drugs Market Segment Percentages, by Type, 2021 (%)
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Global Influenza (Flu) Antiviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Influenza (Flu) Antiviral Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Household
Others
Global Influenza (Flu) Antiviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Influenza (Flu) Antiviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Influenza (Flu) Antiviral Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Influenza (Flu) Antiviral Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
| Report Attributes |
Report Details |
| Report Title |
Influenza (Flu) Antiviral Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Influenza (Flu) Antiviral Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza (Flu) Antiviral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza (Flu) Antiviral Drugs Overall Market Size
2.1 Global Influenza (Flu) Antiviral Drugs Market Size: 2021 VS 2028
2.2 Global Influenza (Flu) Antiviral Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Influenza (Flu) Antiviral Drugs Players in Global Market
3.2 Top Global Influenza (Flu) Antiviral Drugs Companies Ranked by Revenue
3.3 Global Influenza (Flu) Antiviral Drugs Revenue by Companies
3.4 Top 3 and Top 5 Influenza (Flu) Antiviral Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Influenza (Flu) Antiviral Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Influenza (Flu) Antiviral Drugs Players in Global Market
3.6.1 List of Global Tier 1 Influenza (Flu) Antiviral Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Influenza (Flu) Antiviral Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Influenza (Flu) Antiviral Drugs Market Size Markets, 2021 & 2028
4.1.2 Penetration and Dehulling Inhibitors
4.1.3 DNA Polymerase Inhibitors
4.1.4 Reverse Transcriptase Inhibitors
4.1.5 Protein Inhibitors
4.1.6 Neuraminidase Inhibitors
4.1.7 Broad-spectrum Antiviral Drugs
4.2 By Type - Global Influenza (Flu) Antiviral Drugs Revenue & Forecasts
4.2.1 By Type - Global Influenza (Flu) Antiviral Drugs Revenue, 2017-2022
4.2.2 By Type - Global Influenza (Flu) Antiviral Drugs Revenue, 2023-2028
4.2.3 By Type - Global Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza (Flu) Antiviral Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Household
5.1.5 Others
5.2 By Application - Global Influenza (Flu) Antiviral Drugs Revenue & Forecasts
5.2.1 By Application - Global Influenza (Flu) Antiviral Drugs Revenue, 2017-2022
5.2.2 By Application - Global Influenza (Flu) Antiviral Drugs Revenue, 2023-2028
5.2.3 By Application - Global Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Influenza (Flu) Antiviral Drugs Market Size, 2021 & 2028
6.2 By Region - Global Influenza (Flu) Antiviral Drugs Revenue & Forecasts
6.2.1 By Region - Global Influenza (Flu) Antiviral Drugs Revenue, 2017-2022
6.2.2 By Region - Global Influenza (Flu) Antiviral Drugs Revenue, 2023-2028
6.2.3 By Region - Global Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Influenza (Flu) Antiviral Drugs Revenue, 2017-2028
6.3.2 US Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.3.3 Canada Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.3.4 Mexico Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Influenza (Flu) Antiviral Drugs Revenue, 2017-2028
6.4.2 Germany Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4.3 France Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4.4 U.K. Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4.5 Italy Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4.6 Russia Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.4.8 Benelux Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Influenza (Flu) Antiviral Drugs Revenue, 2017-2028
6.5.2 China Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.5.3 Japan Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.5.4 South Korea Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.5.6 India Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Influenza (Flu) Antiviral Drugs Revenue, 2017-2028
6.6.2 Brazil Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.6.3 Argentina Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Influenza (Flu) Antiviral Drugs Revenue, 2017-2028
6.7.2 Turkey Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.7.3 Israel Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
6.7.5 UAE Influenza (Flu) Antiviral Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Influenza (Flu) Antiviral Drugs Major Product Offerings
7.1.4 Pfizer Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Influenza (Flu) Antiviral Drugs Major Product Offerings
7.2.4 Roche Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Influenza (Flu) Antiviral Drugs Major Product Offerings
7.3.4 Sanofi Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Major Product Offerings
7.4.4 Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Corporate Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Major Product Offerings
7.5.4 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.5.5 Merck & Co. (MSD) Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Influenza (Flu) Antiviral Drugs Major Product Offerings
7.6.4 Novartis Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 AbbVie
7.7.1 AbbVie Corporate Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Influenza (Flu) Antiviral Drugs Major Product Offerings
7.7.4 AbbVie Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.7.5 AbbVie Key News
7.8 Gilead Sciences
7.8.1 Gilead Sciences Corporate Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Major Product Offerings
7.8.4 Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.8.5 Gilead Sciences Key News
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Corporate Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.9.5 GlaxoSmithKline (GSK) Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Influenza (Flu) Antiviral Drugs Major Product Offerings
7.10.4 Amgen Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.10.5 Amgen Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Major Product Offerings
7.11.4 AstraZeneca Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Corporate Summary
7.12.2 Bristol-Myers Squibb Business Overview
7.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.12.5 Bristol-Myers Squibb Key News
7.13 Eli Lilly
7.13.1 Eli Lilly Corporate Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Major Product Offerings
7.13.4 Eli Lilly Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.13.5 Eli Lilly Key News
7.14 Teva
7.14.1 Teva Corporate Summary
7.14.2 Teva Business Overview
7.14.3 Teva Influenza (Flu) Antiviral Drugs Major Product Offerings
7.14.4 Teva Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.14.5 Teva Key News
7.15 Bayer
7.15.1 Bayer Corporate Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Influenza (Flu) Antiviral Drugs Major Product Offerings
7.15.4 Bayer Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.15.5 Bayer Key News
7.16 Novo Nordisk
7.16.1 Novo Nordisk Corporate Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Major Product Offerings
7.16.4 Novo Nordisk Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.16.5 Novo Nordisk Key News
7.17 Allergan
7.17.1 Allergan Corporate Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Influenza (Flu) Antiviral Drugs Major Product Offerings
7.17.4 Allergan Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.17.5 Allergan Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Influenza (Flu) Antiviral Drugs Major Product Offerings
7.18.4 Takeda Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.18.5 Takeda Key News
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Corporate Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Major Product Offerings
7.19.4 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Revenue in Global Market (2017-2022)
7.19.5 Boehringer Ingelheim Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Influenza (Flu) Antiviral Drugs Market Opportunities & Trends in Global Market
Table 2. Influenza (Flu) Antiviral Drugs Market Drivers in Global Market
Table 3. Influenza (Flu) Antiviral Drugs Market Restraints in Global Market
Table 4. Key Players of Influenza (Flu) Antiviral Drugs in Global Market
Table 5. Top Influenza (Flu) Antiviral Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Influenza (Flu) Antiviral Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Influenza (Flu) Antiviral Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Influenza (Flu) Antiviral Drugs Product Type
Table 9. List of Global Tier 1 Influenza (Flu) Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza (Flu) Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Influenza (Flu) Antiviral Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Influenza (Flu) Antiviral Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Influenza (Flu) Antiviral Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Influenza (Flu) Antiviral Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Influenza (Flu) Antiviral Drugs Product Offerings
Table 32. Pfizer Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Influenza (Flu) Antiviral Drugs Product Offerings
Table 35. Roche Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Influenza (Flu) Antiviral Drugs Product Offerings
Table 38. Sanofi Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Offerings
Table 41. Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co. (MSD) Corporate Summary
Table 43. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Product Offerings
Table 44. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Influenza (Flu) Antiviral Drugs Product Offerings
Table 47. Novartis Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Corporate Summary
Table 49. AbbVie Influenza (Flu) Antiviral Drugs Product Offerings
Table 50. AbbVie Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Offerings
Table 53. Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline (GSK) Corporate Summary
Table 55. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Offerings
Table 56. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Amgen Corporate Summary
Table 58. Amgen Influenza (Flu) Antiviral Drugs Product Offerings
Table 59. Amgen Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 60. AstraZeneca Corporate Summary
Table 61. AstraZeneca Influenza (Flu) Antiviral Drugs Product Offerings
Table 62. AstraZeneca Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Bristol-Myers Squibb Corporate Summary
Table 64. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Offerings
Table 65. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Eli Lilly Corporate Summary
Table 67. Eli Lilly Influenza (Flu) Antiviral Drugs Product Offerings
Table 68. Eli Lilly Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Teva Corporate Summary
Table 70. Teva Influenza (Flu) Antiviral Drugs Product Offerings
Table 71. Teva Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Bayer Corporate Summary
Table 73. Bayer Influenza (Flu) Antiviral Drugs Product Offerings
Table 74. Bayer Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Novo Nordisk Corporate Summary
Table 76. Novo Nordisk Influenza (Flu) Antiviral Drugs Product Offerings
Table 77. Novo Nordisk Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Allergan Corporate Summary
Table 79. Allergan Influenza (Flu) Antiviral Drugs Product Offerings
Table 80. Allergan Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 81. Takeda Corporate Summary
Table 82. Takeda Influenza (Flu) Antiviral Drugs Product Offerings
Table 83. Takeda Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 84. Boehringer Ingelheim Corporate Summary
Table 85. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Offerings
Table 86. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Influenza (Flu) Antiviral Drugs Segment by Type in 2021
Figure 2. Influenza (Flu) Antiviral Drugs Segment by Application in 2021
Figure 3. Global Influenza (Flu) Antiviral Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Influenza (Flu) Antiviral Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Influenza (Flu) Antiviral Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Influenza (Flu) Antiviral Drugs Revenue in 2021
Figure 8. By Type - Global Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 12. US Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 24. China Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Influenza (Flu) Antiviral Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Influenza (Flu) Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AstraZeneca Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eli Lilly Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Teva Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bayer Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novo Nordisk Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Allergan Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Takeda Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
